Clinical Trial Update: Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study [Phase 4]

View source ↗

Summary

A Phase 4 prospective trial comparing low-dose versus standard-dose alteplase for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Acute Stroke | Phase 4 | Status: COMPLETED